JuliusBirnbaumMD

Assistant Professor of Medicine, Assistant Professor of Neurology, Johns Hopkins University School of Medicine

Are you Dr. Birnbaum?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 92 invites waiting!
Read the latest clinical news, personalized to your specialty.

Dr. Julius Birnbaum, MD is a rheumatologist in Pittsburgh, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania and Maryland. He is affiliated with UPMC Presbyterian Shadyside, UPMC Magee-Womens Hospital, and UPMC Mercy.

Johns Hopkins UniversityFellowship, Rheumatology, 2005 - 2008
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2003 - 2005
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Neurology, 2000 - 2003
Stony Brook Medicine/University HospitalInternship, Internal Medicine, 1998 - 1999
Columbia University Vagelos College of Physicians and SurgeonsClass of 1998

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014

PubMed

18 citations
Ultrasound-Guided Biopsy of Suspected Salivary Gland Lymphoma in Sjögren’s Syndrome
Alan N. Baer, Thomas Grader-Beck, Brendan Antiochos, Julius Birnbaum, Joel Fradin
Arthritis Care & Research. 2021-06-01
26 citations
Biopsy-Proven Small-Fiber Neuropathy in Primary Sjögren's Syndrome: Neuropathic Pain Characteristics, Autoantibody Findings, and Histopathologic Features.
Julius Birnbaum, Aliya Lalji, Aveen Saed, Alan N. Baer
Arthritis Care & Research. 2019-07-01
7 citations
Lupus intestinal pseudo-obstruction and hydronephrosis: Case report.
Brittany L. Adler, Homa Timlin, Julius Birnbaum
Medicine. 2019-07-01

Changes in ICD-10 for Sjögren’S SyndromeOctober 11th, 2019
Study Says Sjögren’s Patients Have a High Specificity for a Novel AntibodySeptember 17th, 2019